Dataset opportunity
Southmedic — Regulatory Records Dataset Opportunity
Moderate regulatory records dataset held by Southmedic, usable for Regulatory RAG and Compliance Copilots.
Score
65.8
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
Acquire
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global AI in regulatory affairs market = $1.31B in 2024, CAGR 18.60%.
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
Profile
Dataset profile
Type
Regulatory Records Dataset
Modality
Text
Sector
healthcare
Volume
Moderate
Freshness
Periodic
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Owned by the company — licensing rights to clarify
Buyer persona
RegTech & compliance-AI vendors
Southmedic holds a Regulatory Records Dataset in Text modality, containing proprietary industrial_data and business records from its Quality Management Systems. This data, which includes evidence for Health Canada and FDA submissions, is highly valuable for training a Regulatory RAG system to automate and improve the accuracy of compliance documentation and queries.
The value of this data is reflected in the global AI in regulatory affairs market, which was valued at $1.31 billion in 2024 and is projected to grow at a CAGR of 18.60%. Despite access complexities due to proprietary manufacturing IP and medical device regulatory constraints, the dataset's rarity and direct applicability make it a high-value asset for AI buyers seeking a competitive edge in this rapidly growing market. ⚠ Diligence (valuable data, access to negotiate): Medical device regulatory constraints (Health Canada/FDA); Proprietary manufacturing IP and trade secrets; Data likely stored in siloed Quality Management Systems (QMS) · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Southmedic holds a proprietary and high-rarity dataset detailing the regulatory, quality, and clinical outcomes of its medical devices. For RegTech and compliance-AI vendors, this is a critical asset for building and training next-generation Regulatory RAG systems. In a global AI in regulatory affairs market projected to reach $1.31 billion in 2024, this unique dataset—spanning manufacturing compliance and distribution to over 80 countries—offers a distinct competitive advantage by providing real-world performance data that is otherwise inaccessible.
See dimension details ↓- Dataset Specificity78
dominant 'regulatory', sector healthcare, 2 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity70
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
periodic
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
fit for Regulatory RAG
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand90
AI buyer demand is high, driven by the need for efficiency and automation in a global AI in regulatory affairs market growing at an 18.60% CAGR.
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility28
restricted/unknown
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility30
medium difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License70
ownership=company_owned, licensing=rights_unclear
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation56
2 data-appetite signals (2 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus70
surplus=medium — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit92
✓ good target — Southmedic is a good target as it's a privately-owned medical device manufacturer and distributor whose core business is selling physical products, not data, and the required regulatory compliance for 80+ countries likely generates a valuable, dormant dataset. Issues: Employee count varies across sources, with the company's own site stating 'over 600' while other sources estimate between 381-500, but it still fits within a br; The 'Regulatory Records Dataset' is an inferred opportunity based on their operational profile, not an explicitly mentioned asset; the value comes from the data
- Deep Qualification90
✓ pass — Southmedic is a medical device manufacturer and distributor. Its core business necessitates the creation and maintenance of extensive regulatory records for bodies like Health Canada and the FDA, making it a prime data_holder with a high-value, proprietary dataset.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Industrial data
This evidence indicates the existence of extensive ISO-compliant production and quality testing datasets, which are foundational for any AI system verifying manufacturing claims for regulatory submissions.
Regulatory records
This evidence confirms the holder possesses proprietary text data on the performance and clinical outcomes of its devices, the ideal fuel for a Regulatory RAG system designed to automate compliance and reporting.
business_records
This evidence confirms a global operational footprint, with distribution records spanning over 80 countries, which strongly suggests the dataset contains documentation relevant to a wide array of international regulatory frameworks.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Southmedic Regulatory Records — a Moderate regulatory records dataset (Text modality) in the healthcare domain. Primary AI use-case: Regulatory RAG. Market signal: Global AI in regulatory affairs market = $1.31B in 2024, CAGR 18.60% (source: Grand View Research). Investment score 65.8/100 (confidence 0.49). Recommended action: Acquire.
From the marketplace
Explore live data opportunities
Docobo — Medical Imaging Dataset Opportunity
View opportunity →healthcareFilab — Industrial Operations Dataset Opportunity
View opportunity →healthcareSniclinic — Medical Imaging Dataset Opportunity
View opportunity →Data Academy
Learn before you deal
- Acquire Rare, Compliant Data3 min read
- Data marketplaces, explained4 min read
- Data licensing, term by term4 min read